Bone growth stimulation, or BGS, is a
type of therapy which is often used to aid in the healing process after a
fracture or spinal fusion surgery. BGS or bone growth stimulation can
help in promoting quicker healing in fractures which make take longer
duration to heal by the natural healing process. Bone growth stimulator
also known as osteogenesis stimulators devices provide pain-free
ultrasound or electrical stimulation and is generally recommended by
orthopedists to help in faster bone healing. Human bones have an innate
ability to heal on their own if there is any spinal fusion process,
surgery, and injury. Bone growth stimulators devices work by releasing
either a low-level pulsed ultrasonic energy or pulsed electromagnetic
field. The energy field fuels bone growth process by helping repair the
damaged body tissues and increase the cell formation and maturity
process, leading to improved bone density.
The major factor contributing to the
growth of the bone growth stimulator market is the rising inclination of
patients towards minimally invasive and non-invasive surgical
treatments and growing population of obese and diabetic population.
Elderly population is particularly vulnerable to bone related injuries
and fractures. Globally the number of elderly population- people aged 60
years or over has grown significantly in most of the countries in the
recent years and that this growth is anticipated to accelerate in the
coming years. According to United Nations 2015 report, globally the
number of people aged 60 years or more were 901 million in 2015 from 607
million observed in 2000. The elderly population is slated to increase
by 56% to 1.4 billion by 2030 and is projected increase twofold from its
size in 2015, reaching nearly 2.1 billion by 2050. Thus the growing
aging population is anticipated to propel the growth of the market
during the forecast period. Additionally, the cost benefits offered by
the bone stimulation devices for bone fracture treatments are some of
the key factors driving the growth of bone growth stimulator market. On
the contrary, side effects associated with orthopedic treatment and
legal litigations against market players are some of the restraining
factors that could affect the growth of the bone growth stimulator
market during the forecast period.
The global bone growth stimulator market
is segmented based on product type, by application, by end user type and
by geography. In terms of product type, bone growth stimulator market
is categorized into external and implantable devices. In terms of
application, the market is classified into delayed nonunion and union
bone fractures, spinal fusion surgeries, maxillofacial and dental
surgeries. Based on end-user type, the bone growth stimulators market is
classified into specialty clinics, homecare settings, and hospitals.
Geographically global bone growth
stimulators market is segmented into North America, Europe, Asia
Pacific, Latin America & Middle East and Africa. North America
accounted for the largest share of the market due to improved
reimbursement policies and upsurge in the investments in
healthcare-service sector. The region is projected to maintain its lead
in terms of overall market share primarily due to the growing awareness
levels among the population regarding chronic injuries and bone
fractures, and the growing investments by major manufacturers in
research and development of technologically advanced devices. Asia
Pacific is expected to witness the fastest growth rate due to increasing
elderly population in the region. The high percentage of elderly
population in developing countries such as China and Japan are
increasing the incidences of bone fractures & spinal fusion surgical
procedures in the Asia Pacific region
To maintain a significant position in the
market the key players in the global bone growth stimulators market are
operating strategies such as mergers and acquisitions, cost effective
and efficient products, collaborative partnerships etc. The major
players reported in the market include Orthofix International N.V,
Zimmer Biomet Holdings Inc., Bioventus LLC., Synergy Orthopedics, ITO
Physiotherapy & Rehabilitation, DePuy Synthes Spine, Inc., DJO
Global, Inc Ossatec Benelux Ltd., and Orchid Medical.
No comments:
Post a Comment